Flattening the curve in 52 days: characterisation of the COVID-19 pandemic in the Principality of Liechtenstein - an observational study

被引:4
|
作者
Sarah, Thiel L. [1 ]
Myriam, Weber C. [1 ]
Lorenz, Risch [2 ,3 ,4 ]
Nadia, Wohlwend [2 ]
Thomas, Lung [2 ]
Dorothea, Hillmann [2 ]
Michael, Ritzier [2 ]
Martin, Risch [5 ]
Philipp, Kohler [6 ,7 ]
Pietro, Vernazza [6 ,7 ]
Christian, Kahlert R. [6 ,7 ,8 ,9 ]
Felix, Fleisch [10 ,11 ]
Alexia, Cusini [10 ,11 ]
Tomas, Karajan, V [1 ]
Sandra, Copeland [1 ]
Matthias, Paprotny [1 ]
机构
[1] Landesspital Liechtenstein, Dept Gen Internal Med, Vaduz, Liechtenstein
[2] Labormed Zentrum Dr Risch, Vaduz, Liechtenstein
[3] Univ Bern, Univ Inst Clin Chem, Ctr Lab Med, Bern, Switzerland
[4] Private Univ Principal Liechtenstein, Triesen, Liechtenstein
[5] Kantonsspital Graubunden, Cent Lab, Chur, Switzerland
[6] Kantonsspital St Gallen, Div Infect Dis, St Gallen, Switzerland
[7] Kantonsspital St Gallen, Hosp Epidemiol, St Gallen, Switzerland
[8] Childrens Hosp Eastern Switzerland, Dept Infect Dis, St Gallen, Switzerland
[9] Childrens Hosp Eastern Switzerland, Hosp Epidemiol, St Gallen, Switzerland
[10] Kantonsspital Graubunden, Div Infect Dis, Chur, Switzerland
[11] Kantonsspital Graubunden, Hosp Epidemiol, Chur, Switzerland
关键词
antibody; COVID-19; epidemiology; incidence; nicotine; pandemic; public health; mortality; RTPCR;
D O I
10.4414/smw.2020.20361
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: The principality of Liechtenstein had its first COVID-19 case at the beginning of March 2020. After exponential growth, the pandemic's first wave was contained, with the last case being diagnosed 52 days after the initial occurrence. AIM: To characterise the COVID-19 pandemic in Liechtenstein. METHODS: All patients diagnosed in Liechtenstein were followed up until recovery and again 6-8 weeks after symptom onset. They were contacted every 2 days to record their clinical status until the resolution of their symptoms. The diagnosis of COVID-19 was based on clinical symptoms and molecular testing. Household and close workplace contacts were included in the follow-up, which also comprised antibody testing. In addition, public health measures installed during the pandemic in Liechtenstein are summarised. RESULTS: During the first wave, 5% of the population obtained a reverse transcriptase polymerase chain reaction test. A total of 95 patients (median age 39 years) were diagnosed with COVID-19 (82 who resided in Liechtenstein), resulting in an incidence in Liechtenstein of 0.211%. One patient, aged 94, died (mortality rate 1%). Only 62% of patients could retrospectively identify a potential source of infection. Testing the patients' household and close workplace contacts (n = 170) with antibody tests revealed that 25% of those tested were additional COVID-19 cases, a quarter of whom were asymptomatic. Those households which adhered to strict isolation measures had a significantly lower rate of affected household members than those who didn't follow such measures. The national public health measures never restricted free movement of residents. Masks were only mandatory in healthcare settings The use of home working for the general workforce was promoted. Gatherings were prohibited. Schools, universities, certain public spaces (like sports facilities and playgrounds), childcare facilities, nonessential shops, restaurants and bars were closed. Social distancing, hygienic measures, solidarity and supporting individuals who were at risk were the main pillars of the public health campaigns. CONCLUSION: The close collaboration of all relevant stakeholders allowed for the complete workup of all COVID-19 patients nationwide. A multitude of factors (e.g., young age of the patients, low-threshold access to testing, close monitoring of cases, high alertness and adherence to public health measures by the population) led to the early containment of the first wave of the pandemic, with a very low rate of serious outcomes. Antibody testing for SARS-CoV-2 revealed a substantial proportion of undiagnosed COVID-19 cases among close contacts of the patients.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Flattening the COVID-19 Curve: The Unique Role of Emergency Medical Services in Containing a Global Pandemic
    Jaffe, Eli
    Sonkin, Roman
    Alpert, Evan Avraham
    Magid, Avi
    Knobler, Haim Y.
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2020, 22 (08): : 410 - 416
  • [22] Flattening the other curve: Reducing emergency department STEMI delays during the COVID-19 pandemic
    McLaren, Jesse T. T.
    Taher, Ahmed K.
    Chartier, Lucas B.
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2021, 49 : 367 - 372
  • [23] Flattening the COVID-19 Curve: The Impact of Contact Restrictions on the Infection Curve in Germany
    Valentowitsch, Johann
    GESUNDHEITSWESEN, 2020, 82 (07) : 646 - 648
  • [24] Collaboration-competition dilemma in flattening the COVID-19 curve
    Van Oorschot, Kim E.
    Van Wassenhove, Luk N.
    Jahre, Marianne
    PRODUCTION AND OPERATIONS MANAGEMENT, 2023, 32 (05) : 1345 - 1361
  • [25] Comment on "Poorly known aspects of flattening the curve of COVID-19"
    Daud, Auni Aslah Mat
    TECHNOLOGICAL FORECASTING AND SOCIAL CHANGE, 2021, 167
  • [26] Flattening the Curve for Incarcerated Populations - Covid-19 in Jails and Prisons
    Akiyama, Matthew J.
    Spaulding, Anne C.
    Rich, Josiah D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (22): : 2075 - 2077
  • [27] Dental Practice during COVID-19 Pandemic: An Observational Study
    Prajapati, Aalap Sureshkumar
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2021, 15 (03)
  • [28] ANTEPARTUM DISTRESS DURING COVID-19 PANDEMIC: AN OBSERVATIONAL STUDY
    Di Buo, Agata
    Moretti, Patrizia
    Menculini, Giulia
    Minuti, Agnese
    Valentini, Eleonora
    Cerasoli, Ilaria
    Mancini, Niccolo
    Moro, Benedetta
    Radici, Sara
    Gerli, Sandro
    Tortorella, Alfonso
    PSYCHIATRIA DANUBINA, 2021, 33 : S137 - S141
  • [29] Being a Urologist on COVID-19 Pandemic Days
    Ozman, Oktay
    UROLOGY JOURNAL, 2020, 17 (05) : 555 - 556
  • [30] Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies
    Market, Marisa
    Angka, Leonard
    Martel, Andre B.
    Bastin, Donald
    Olanubi, Oladunni
    Tennakoon, Gayashan
    Boucher, Dominique M.
    Ng, Juliana
    Ardolino, Michele
    Auer, Rebecca C.
    FRONTIERS IN IMMUNOLOGY, 2020, 11